CD274 and primary biliary cholangitis: ARON-2EV (NCT05290038) was designed as an international, retrospective, multicenter study to collect global real-world data on EV use in patients with mUC who progressed after previous PBC and anti-PD-1/PD-L1 inhibitor therapy.